Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.4%, Outperforms Peers

Dow Jones2026/08/07 20:35

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rallied 4.4% to $10.17 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.

This was the stock's fourth consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 50.5% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 2.2% to $5.00, Fortress Biotech Inc. fell 3.6% to $2.67, and Viking Therapeutics Inc. rose 2.88% to $34.26.

Trading volume totaled 352,885, compared to the 50-day average of 447,114.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 07, 2026 16:35 ET (20:35 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Renowned financial journalist Mark Gurman stated that Apple’s first foldable iPhone has the potential to elevate the still-experimental foldable phone category to an industry standard. He noted that this device, called the iPhone Duo, is one of Apple’s most influential products, ranking just behind the iMac, iPod, iPad, and Apple Watch.

智通财经•2026/09/13 23:31